Efficacy and Safety of a Diabetic Blenderized Diet Using Isomaltulose
Keywords:
blenderized diet, isomatulose, fructose, maltodextrin, diabetes mellitus, rapidly available glucoseAbstract
Objective: To determine the efficacy and safety of a diabetes blenderized diet (BDDM) using Isomaltulose,
which has a low glycemic index (32), instead of using fructose and maltodextrin in the BDDM(Std).
Methods: Various BDDM recipes with Isomaltulose were developed. The glycemic index of BDDM was assessed by the in vitro Rapidly Available Glucose (in vitro RAG) technique and their flow rates were studied. The area under the curve (AUC) of blood glucose, insulin and lipid level were evaluated. Thus, the sensory
acceptance, including hunger and fullness, were tested before and at 15, 30, 60, 90, 120, 240 minutes, during a 4 hour period in 20 Type 2 diabetes patients.
Results: The in vitro RAG of BDDM(Std) and BDDM(Iso) 1-4 showed 1.38-5.50 g/100 ml. All BBDM showed low glycemic index levels. However, the BDDM(Iso) 4 had the fastest flow rates.
A further comparison between BDDM(Iso) 4 and BDDM(Std) noted that the glucose AUC during 4 hours in the BDDM(Iso) 4 (892.4 ± 112.7 mg min / dL) was lower than that of BDDM(Std) 913.6 ± 138.7 mg min/dL), but the results were not significantly different (p-value = 0.6394). The AUC of insulin and lipid levels between BDDM were also not significantly different. However, BDDM(Iso) tends to be more accepted for taste and fullness when compared to BDDM(Std).
Conclusion: BDDM (Iso)is not significantly different from BDDM (Std) in levels of glucose, insulin, and lipid. However, BDDM (Iso) tends to be more widely accepted by taste and fullness than BDDM (Std).
References
International Diabetes Federation. IDF Diabetes Atlas 8th edition 2017 [cited 2021 Mar 13]. Available from: https://diabetesatlas.org
American Diabetes Association. 5. Lifestyle management: Standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1): S46-s60.
Papier K, D’Este C, Bain C, Banwell C, Seubsman S, Sleigh A, et al. Consumption of sugar-sweetened beverages and type 2 diabetes incidence in Thai adults: results from an 8-year prospective study. Nutr Diabetes. 2017;7(6): e283.
Schulze MB, Manson JE, LudwigDS, Colditz GA, Stampfer MJ, Willett WC, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004;292(8):927-34.
Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care. 2008;31(12):2281-3.
Maresch CC, Petry SF, Theis S, Bosy-Westphal A, Linn T. Low glycemic index prototype isomaltulose-update of clinical trials. Nutrients. 2017;9(4).
Egi M, Toda Y, Katayama H, Yokoyama M, Morita K, Arai H, et al. Safer glycemic control using isomaltulose-based enteral formula: a pilot randomized crossover trial. J Crit Care. 2010;25(1):90-6.
Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, et al. Glycaemic index methodology. Nutrition Research Reviews. Cambridge University Press; 2005; 18(1):145–71.
Englyst HN, Veenstra J, Hudson GJ. Measurement of rapidly available glucose (RAG) in plant foods: a potential in vitro predictor of the glycaemic response. Br J Nutr. 1996;75(3):327-37.
Englyst KN, Englyst HN, Hudson GJ, Cole TJ, Cummings JH. Rapidly available glucose in foods: an in vitro measurement that reflects the glycemic response. Am J Clin Nutr. 1999;69(3):448-54.
Tiefenbacher KF. Technology of main ingredients—sweeteners and lipids. Wafer and Waffle. 2017;123:225.
Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76(1):5-6.
Suklaew PO. Postprandial metabolic change of the first high-fat meal with an isomaltulose-based beverage followed by the second regular meal in obese men [dissertation]. Bangkok: Chulalongkorn University; 2014.
Camps SG, Koh HR, Wang NX, Henry CJ. High fructose consumption with a high-protein meal is associated with decreased glycemia and increased thermogenesis but reduced fat oxidation: a randomized controlled trial. Nutrition. 2019;58:77-82.
Guérin-Deremaux L, Pochat M, Reifer C, Wils D, Cho S, Miller LE. The soluble fiber NUTRIOSE induces a dose-dependent beneficial impact on satiety over time in humans. Nutrition Research. 2011;31(9):665-72.
García-Rodríguez CE, Mesa MD, Olza J, Buccianti G, Pérez M, Moreno-Torres R, Pérez de la Cruz A, Gil A. Postprandial glucose, insulin and gastrointestinal hormones in healthy and diabetic subjects fed a fructose-free and resistant starch type IV-enriched enteral formula. Eur J Clin Nutr. 2013;52:1569-78.
König D, Zdzieblik D, Holz A, Theis S, Gollhofer A. Substrate utilization and cycling performance following palatinose™ ingestion: A randomized, double-blind, controlled trial. Nutrients. 2016;8(7):390.
West DJ, Morton RD, Stephens JW, Bain SC, Kilduff LP, Luzio S, Still R, Bracken RM. Isomaltulose improves postexercise glycemia by reducing CHO oxidation in T1DM. Med Sci Sports Exerc. 2011;43(2):204-10.
Brunner S, Holub I, Theis S, Gostner A, Melcher R, Wolf P, Amann-Gassner U, Scheppach W, Hauner H. Metabolic effects of replacing sucrose by isomaltulose in subjects with type 2 diabetes: a randomized double-blind trial. Diabetes care. 2012 ;35(6):1249-51.
Kashimura J, Nakajima Y, Benno Y, Mitsuoka T. Comparison of fecal microflora among subjects given palatinose and its condensates. Nippon Eiyo Shokuryo Gakkaishi. 1990;43:175-80.
Taskinen MR, Packard CJ, Borén J. Dietary fructose and the metabolic syndrome. Nutrients. 2019; 11(9):1987.
Welsh JA, Sharma A, Abramson JL, Vaccarino V, Gillespie C, Vos MB. Caloric sweetener consumption and dyslipidemia among US adults. JAMA. 2010;303(15):1490-7.
Sánchez-Lozada LG, Le M, Segal M, Johnson RJ. How safe is fructose for persons with or without diabetes?. Am J Clin Nutr. 2008;88(5):1189-90.
Rizkalla SW. Health implications of fructose consumption: A review of recent data. Nutr Metab. 2010;7:1-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Thai JPEN วารสารโภชนบำบัด

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The content and information in the articles published in Thai JPEN วารสารโภชนบำบัด, are the opinions and responsibility of the authors directly. The editorial team is not obliged to agree or take any responsibility.
All articles, content, figures, etc. that have been published in Thai JPEN วารสารโภชนบำบัด are the copyright of Thai JPEN วารสารโภชนบำบัด. If any person or organization require distribution of all or any part of them, please send the request for the written permission from Thai JPEN วารสารโภชนบำบัด only.